137 related articles for article (PubMed ID: 15167216)
21. Predominant genotypes and alleles of two functional polymorphisms in the manganese superoxide dismutase gene are not associated with Thai cervical or breast cancer.
Attatippaholkun W; Wikainapakul K
Asian Pac J Cancer Prev; 2013; 14(6):3955-61. PubMed ID: 23886214
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the contribution of cyclooxygenase 2 genotypes to breast cancer in Taiwan.
Su CH; Hsiao CL; Chang WS; Liu LC; Wang HC; Tsai CW; Li LY; Tsai CH; Bau DT
Anticancer Res; 2014 Nov; 34(11):6711-6. PubMed ID: 25368279
[TBL] [Abstract][Full Text] [Related]
23. HER2 polymorphisms and breast cancer in Tunisian women.
Kallel I; Kharrat N; Al-fadhly S; Rebai M; Khabir A; Boudawara TS; Rebaï A
Genet Test Mol Biomarkers; 2010 Feb; 14(1):29-35. PubMed ID: 19929405
[TBL] [Abstract][Full Text] [Related]
24. HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.
Watrowski R; Castillo-Tong DC; Wolf A; Schuster E; Fischer MB; Speiser P; Zeillinger R
Anticancer Res; 2015 Dec; 35(12):6667-70. PubMed ID: 26637882
[TBL] [Abstract][Full Text] [Related]
25. HER-2/neu gene codon 655 (Ile/Val) polymorphism in breast carcinoma patients.
Sezgin E; Sahin FI; Yagmurdur MC; Demirhan B
Genet Test Mol Biomarkers; 2011 Mar; 15(3):143-6. PubMed ID: 21204706
[TBL] [Abstract][Full Text] [Related]
26. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
27. Murine double minute clone 2,309T/G and 285G/C promoter single nucleotide polymorphism as a risk factor for breast cancer: a Polish experience.
Piotrowski P; Lianeri M; Rubis B; Knuła H; Rybczyńska M; Grodecka-Gazdecka S; Jagodziński PP
Int J Biol Markers; 2012 Jul; 27(2):e105-10. PubMed ID: 22467100
[TBL] [Abstract][Full Text] [Related]
28. HER2 Ile655Val polymorphism contributes to breast cancer risk: evidence from 27 case-control studies.
Lu S; Wang Z; Liu H; Hao X
Breast Cancer Res Treat; 2010 Dec; 124(3):771-8. PubMed ID: 20401632
[TBL] [Abstract][Full Text] [Related]
29. Ile to Val polymorphism at codon 655 of HER-2 gene and breast cancer risk in Iranian women.
Kamali-Sarvestani E; Talei AR; Merat A
Cancer Lett; 2004 Nov; 215(1):83-7. PubMed ID: 15374636
[TBL] [Abstract][Full Text] [Related]
30. No association between HER-2 gene polymorphism at codon 655 and a risk of bladder cancer.
Wang L; Habuchi T; Takahashi T; Kamoto T; Zuo T; Mitsumori K; Tsuchiya N; Sato K; Ogawa O; Kato T
Int J Cancer; 2002 Feb; 97(6):787-90. PubMed ID: 11857355
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of breast cancer susceptibility loci on 2q35, 3p24, 17q23 and FGFR2 genes in Taiwanese women with breast cancer.
Lin CY; Ho CM; Bau DT; Yang SF; Liu SH; Lin PH; Lin TH; Tien N; Shih MC; Lu JJ
Anticancer Res; 2012 Feb; 32(2):475-82. PubMed ID: 22287734
[TBL] [Abstract][Full Text] [Related]
32. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
[TBL] [Abstract][Full Text] [Related]
33. Genetic susceptibility of catechol-O-methyltransferase polymorphism in Japanese patients with breast cancer.
Inoue H; Shibuta K; Matsuyama A; Yoshinaga K; Sadanaga N; Ueo H; Barnard GF; Mori M
Oncol Rep; 2005 Sep; 14(3):707-12. PubMed ID: 16077979
[TBL] [Abstract][Full Text] [Related]
34. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
35. Lack of replication for the association between HER2 I655V polymorphism and breast cancer risk: a systematic review and meta-analysis.
Dahabreh IJ; Murray S
Cancer Epidemiol; 2011 Dec; 35(6):503-9. PubMed ID: 21474413
[TBL] [Abstract][Full Text] [Related]
36. A single nucleotide polymorphism in the transmembrane domain coding region of HER-2 is associated with development and malignant phenotype of gastric cancer.
Kuraoka K; Matsumura S; Hamai Y; Nakachi K; Imai K; Matsusaki K; Oue N; Ito R; Nakayama H; Yasui W
Int J Cancer; 2003 Nov; 107(4):593-6. PubMed ID: 14520697
[TBL] [Abstract][Full Text] [Related]
37. [Association between single nucleotide polymorphisms of BARD 1 gene and susceptibility of early-onset breast cancer in Uygur women in Xinjiang].
Sun G; Wang JT; Ma BL; Geng ZL; Ren GH; Shan MH; Ma B; Ma LL; Wang Y
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):341-7. PubMed ID: 22883453
[TBL] [Abstract][Full Text] [Related]
38. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
[TBL] [Abstract][Full Text] [Related]
39. Genetic polymorphisms in inflammatory response genes and their associations with breast cancer risk.
Wang Z; Liu QL; Sun W; Yang CJ; Tang L; Zhang X; Zhong XM
Croat Med J; 2014 Dec; 55(6):638-46. PubMed ID: 25559835
[TBL] [Abstract][Full Text] [Related]
40. Genetic Polymorphism of SUMO-Specific Cysteine Proteases - SENP1 and SENP2 in Breast Cancer.
Mirecka A; Morawiec Z; Wozniak K
Pathol Oncol Res; 2016 Oct; 22(4):817-23. PubMed ID: 27178176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]